Literature DB >> 2062836

Potent cytodifferentiating agents related to hexamethylenebisacetamide.

R Breslow1, B Jursic, Z F Yan, E Friedman, L Leng, L Ngo, R A Rifkind, P A Marks.   

Abstract

Bishydroxamic acids are effective inducers of differentiation in murine erythroleukemia cells. Flexible analogs of suberic acid bisdimethylamide are approximately 100 times as active as the parent compound or hexamethylenebisacetamide. They also induce differentiation of human promyelocytic leukemia cells (HL-60) and a subclone of human colon carcinoma cells (HT-29-U4). Some rigid bishydroxamic acids with benzene rings in the spacers are even more active toward murine erythroleukemia cells but show curious biological differences. In contrast to the flexible molecules, those with benzene spacers show poor activity toward HL-60 cells; they also have different geometric requirements, and they are not additive with hexamethylenebisacetamide in their effect. It is likely that rigid bishydroxamic acids, with a benzene ring spacer, induce differentiation by a different mechanism in spite of their chemical resemblance to the flexible bisamide and bishydroxamic acid inducers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062836      PMCID: PMC51913          DOI: 10.1073/pnas.88.13.5542

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Effect on in vivo tumorigenicity of lengthy exposure of human colon cancer cells to the differentiation agent hexamethylene bisacetamide.

Authors:  P Schroy; S Winawer; E Friedman
Journal:  Cancer Lett       Date:  1989-11-15       Impact factor: 8.679

2.  Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds.

Authors:  M Tanaka; J Levy; M Terada; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

3.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

Review 4.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

5.  Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.

Authors:  M J Egorin; L M Sigman; D A Van Echo; A Forrest; M Y Whitacre; J Aisner
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

6.  Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.

Authors:  E Melloni; S Pontremoli; M Michetti; O Sacco; A G Cakiroglu; J F Jackson; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.

Authors:  M M Hafez; D Infante; S Winawer; E Friedman
Journal:  Cell Growth Differ       Date:  1990-12

8.  Chemical differentiating agents. Differentiation of HL-60 cells by hexamethylenebis[acetamide] analogues.

Authors:  A Haces; T R Breitman; J S Driscoll
Journal:  J Med Chem       Date:  1987-02       Impact factor: 7.446

9.  Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds.

Authors:  R C Reuben; P L Khanna; Y Gazitt; R Breslow; R A Rifkind; P A Marks
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

10.  A new group of potent inducers of differentiation in murine erythroleukemia cells.

Authors:  R C Reuben; R L Wife; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

View more
  13 in total

1.  Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Authors:  V M Richon; Y Webb; R Merger; T Sheppard; B Jursic; L Ngo; F Civoli; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.

Authors:  Brian M Zeglis; NagaVaraKishore Pillarsetty; Vadim Divilov; Ronald A Blasberg; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2011-03-03       Impact factor: 2.408

3.  Lead optimization of HMBA to develop potent HEXIM1 inducers.

Authors:  Bo Zhong; Rati Lama; Wannarasmi Ketchart; Monica M Montano; Bin Su
Journal:  Bioorg Med Chem Lett       Date:  2014-01-17       Impact factor: 2.823

4.  Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

Authors:  L Qiu; A Burgess; D P Fairlie; H Leonard; P G Parsons; B G Gabrielli
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

5.  A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

Authors:  V M Richon; S Emiliani; E Verdin; Y Webb; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.

Authors:  Erin T Larragoite; Racheal A Nell; Laura J Martins; Louis R Barrows; Vicente Planelles; Adam M Spivak
Journal:  Biochem Pharmacol       Date:  2021-11-18       Impact factor: 5.858

7.  Adsorption properties of polar/apolar inducers at a charged interface and their relevance to leukemia cell differentiation.

Authors:  M Carlà; M Cuomo; A Arcangeli; M Olivotto
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

8.  The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation.

Authors:  Yuval Samuni; Wilmarie Flores-Santana; Murali C Krishna; James B Mitchell; David A Wink
Journal:  Free Radic Biol Med       Date:  2009-05-15       Impact factor: 7.376

Review 9.  Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process.

Authors:  P A Marks; V M Richon; H Kiyokawa; R A Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Polar/apolar compounds induce leukemia cell differentiation by modulating cell-surface potential.

Authors:  A Arcangeli; M Carlà; M R Del Bene; A Becchetti; E Wanke; M Olivotto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.